Jimmy Carter’s Melanoma drug on the verge of ?breakthrough?
In 2014, FDA gave pembrolizumab accelerated approval for melanoma.? Today, the 3-year survival rate in melanoma patients is reported to be 40%.? ASCO president Dr. Julie Vose told NBC News, “…
